Kenneth T. Mills
2021
In 2021, Kenneth T. Mills earned a total compensation of $8.6M as President and CEO at Regenxbio, a 13% increase compared to previous year.
Compensation breakdown
| Bonus | $600,000 |
|---|---|
| Non-Equity Incentive Plan | $473,854 |
| Option Awards | $5,057,556 |
| Salary | $631,805 |
| Stock Awards | $1,843,050 |
| Other | $16,675 |
| Total | $8,622,941 |
Mills received $5.1M in option awards, accounting for 59% of the total pay in 2021.
Mills also received $600K in bonus, $473.9K in non-equity incentive plan, $631.8K in salary, $1.8M in stock awards and $16.7K in other compensation.
Rankings
In 2021, Kenneth T. Mills' compensation ranked 1,304th out of 12,405 executives tracked by ExecPay. In other words, Mills earned more than 89.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,304 out of 12,405 | 90th |
Division Manufacturing | 459 out of 5,494 | 92nd |
Major group Chemicals And Allied Products | 166 out of 2,369 | 93rd |
Industry group Drugs | 138 out of 2,090 | 93rd |
Industry Biological Products, Except Diagnostic Substances | 40 out of 452 | 91st |
Pay ratio
| Kenneth T. Mills' Pay | $8,622,941 |
|---|---|
| Median Employee's Pay | $176,342 |
| Pay Ratio | 49to 1 |
In 2021, the annual total compensation of Kenneth T. Mills was $8,622,941.
The annual total compensation of the median employee at Regenxbio was $176,342.
The ratio of Kenneth T. Mills' pay to the pay of median employee was therefore 49 to one.
Source: SEC filing on April 7, 2022.
Mills' colleagues
We found four more compensation records of executives who worked with Kenneth T. Mills at Regenxbio in 2021.